Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 08/15/19

Igor A. Kuzmin, Ph.D.

Igor A. Kuzmin, Ph.D.

Program Director

Translational Research Program

Division of Cancer Treatment and Diagnosis,
National Cancer Institute
9609 Medical Center Drive, Room 3W112
MSC 9726
Bethesda, MD 20892
Phone (240) 276-5730
Fax (240) 276-7881

Igor A. Kuzmin, Ph.D. is a Program Director at the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). Dr. Kuzmin manages Specialized Programs of Research Excellence (SPOREs) in hematological malignancies and kidney cancer.

Prior to his appointment at the NCI, Dr. Kuzmin served as a senior scientist at SAIC-Frederick, Inc., a subsidiary of Science Applications International Corporation that provides research support to various NCI programs. He contributed to identification of several cancer-related genes on human chromosome 3p, including the von Hippel-Lindau disease tumor suppressor gene, RASSF1A, and FUS1. He authored 35 professional publications.

Dr. Kuzmin received his M.S. from St. Petersburg State University, and a Ph.D. from the Institute of Cytology, Russian Academy of Sciences. Dr. Kuzmin’s training includes postdoctoral fellowship at the NCI intramural program. He is board certified in the United States regulatory affairs by the Regulatory Affairs Professional Society. He holds Regulatory Compliance Certificate from Hood College. Dr. Kuzmin is a member of the American Association for Cancer Research.